Literature DB >> 6286763

Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

D Benjamin, I T Magrath, R Maguire, C Janus, H D Todd, R G Parsons.   

Abstract

As part of an investigation of the cellular origins of undifferentiated lymphomas of the Burkitt's and non-Burkitt's types, we have examined immunoglobulin secretion by cell lines and biopsy samples from these tumors and have compared it with other lymphoblastoid cell lines. The majority of American lymphoma cell lines and a smaller fraction of African lymphoma cell lines secreted monoclonal IgM. No other Ig classes were secreted. Ig secretion by the tumor samples was also found to be exclusively IgM. The secreted IgM was polymeric and associated with J chain. Secretion of free light chain by most of the tumor cell lines was observed. Quantitation by immunoassay demonstrated that the American lymphoma cell lines secreted significantly more IgM than the African lymphoma cell lines. We have proposed that the lymphoma cells represent an early stage of B cell differentiation, during which antigen-independent secretion occurs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

Authors:  Min H Kang; Malcolm A Smith; Christopher L Morton; Nino Keshelava; Peter J Houghton; C Patrick Reynolds
Journal:  Pediatr Blood Cancer       Date:  2010-10-04       Impact factor: 3.167

2.  Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.

Authors:  Rhonda L Taylor; Mark N Cruickshank; Mahdad Karimi; Han Leng Ng; Elizabeth Quail; Kenneth M Kaufman; John B Harley; Lawrence J Abraham; Betty P Tsao; Susan A Boackle; Daniela Ulgiati
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

3.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

4.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region.

Authors:  L C Showe; M Ballantine; K Nishikura; J Erikson; H Kaji; C M Croce
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

6.  A novel method for assaying human regulatory T cell direct suppression of B cell effector function.

Authors:  Elizabeth Weingartner; Jean-Paul Courneya; Achsah Keegan; Amit Golding
Journal:  J Immunol Methods       Date:  2016-11-13       Impact factor: 2.303

7.  Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.

Authors:  N Jochner; D Eick; U Zimber-Strobl; M Pawlita; G W Bornkamm; B Kempkes
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

8.  Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells.

Authors:  W Sherman; Z Liu; G Inghirami; E F Reed; P E Harris; N M Suciu-Foca
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

9.  IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Authors:  Elisa Ferretti; Emma Di Carlo; Emanuela Ognio; Giulio Fraternali-Orcioni; Anna Corcione; Beatrice Belmonte; Jean Louis Ravetti; Claudio Tripodo; Domenico Ribatti; Vito Pistoia
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

10.  Screening for residual disease in pediatric burkitt lymphoma using consensus primer pools.

Authors:  Melissa Agsalda; Ian Kusao; David Troelstrup; Bruce Shiramizu
Journal:  Adv Hematol       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.